These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15625522)

  • 1. Newer imaging modalities to assess tumor in the prostate.
    Hersh MR; Knapp EL; Choi J
    Cancer Control; 2004; 11(6):353-7. PubMed ID: 15625522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
    Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
    Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].
    Baccos A; Schiavina R; Zukerman Z; Busato F; Gaudiano C; Salizzoni E; Fiorentino M; Golfieri R; Martorana G
    Urologia; 2012; 79(2):116-22. PubMed ID: 22522463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.
    Amsellem-Ouazana D; Younes P; Conquy S; Peyromaure M; Flam T; Debré B; Zerbib M
    Eur Urol; 2005 May; 47(5):582-6. PubMed ID: 15826747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer.
    Thompson J; Lawrentschuk N; Frydenberg M; Thompson L; Stricker P;
    BJU Int; 2013 Nov; 112 Suppl 2():6-20. PubMed ID: 24127671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does endorectal MRI, PET-CT and transrectal ultrasound contribute to diagnosis and management of localized prostate cancer.
    Rincón Mayans A; Diaz-Tejeiro BZ; Rioja Zuazu J; Díaz Dorronsoro L; Rodriguez Fraile M; Boillos AB; Bergera JZ
    Arch Esp Urol; 2011 Oct; 64(8):746-64. PubMed ID: 22052757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer imaging.
    Fuchsjäger M; Shukla-Dave A; Akin O; Barentsz J; Hricak H
    Acta Radiol; 2008 Feb; 49(1):107-20. PubMed ID: 18210320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MRI staging of prostate cancer with the combined endorectal body phased-array coil and histologic correlation].
    Pegios W; Bentas W; Wittmann L; Mack MG; Zangos S; Söllner O; Binder J; Fellbaum C; Jonas D; Vogl TJ
    Rofo; 2003 Dec; 175(12):1660-6. PubMed ID: 14661137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy.
    Yuen JS; Thng CH; Tan PH; Khin LW; Phee SJ; Xiao D; Lau WK; Ng WS; Cheng CW
    J Urol; 2004 Apr; 171(4):1482-6. PubMed ID: 15017203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods].
    Böni RA; Hutter BE; Trinkler F; Jochum W; Pestalozzi D; Krestin GP
    Rofo; 1996 Aug; 165(2):152-8. PubMed ID: 8924668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging in prostate cancer diagnosis: present role and future perspectives.
    Pinto F; Totaro A; Calarco A; Sacco E; Volpe A; Racioppi M; D'Addessi A; Gulino G; Bassi P
    Urol Int; 2011; 86(4):373-82. PubMed ID: 21372554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New imaging techniques in prostate cancer.
    Trabulsi EJ; Merriam WG; Gomella LG
    Curr Urol Rep; 2006 May; 7(3):175-80. PubMed ID: 16630520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: local staging with endorectal magnetic resonance imaging.
    Sheu MH; Wang JH; Chen KK; Chiang H; Teng MH
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):243-52. PubMed ID: 9650427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.
    Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J
    AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and spectroscopic imaging of prostate cancer.
    Coakley FV; Qayyum A; Kurhanewicz J
    J Urol; 2003 Dec; 170(6 Pt 2):S69-75; discussion S75-6. PubMed ID: 14610414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.